POT reached the $1 million cap in April 2014 but tanked immediately to $244,000 less than a month later. It looked as if it was staying on a downward trend until NBA legend Dennis Rodman wore a PotCoin.com shirt in a North Korean airport. As of January 2020 POT was priced at $0.0056 and is projected to be at $0.60 by the end of 2022.
Cannabics Pharmaceuticals (CNBX) receives "Intention to Grant a European Patent"
In the podcast, Mr. Teeple will discuss the current state of Can B Corp, along with its subsidiaries, new product launches, its FDA approved medical device and its strong medical advisory team.
Miami, FL –October 22, 2020, 2020 (EmergingGrowth.com NewsWire) — EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled...
Cannabics Pharmaceuticals (CNBX) Prepares to Submit the FDA with a pre-IND Meeting Request for its Proprietary Colon Cancer Drug Candidate, CANNABICS™ RCC-33
PAO Group, Inc. (PAOG) FDA Application Process For Respiratory Cannabis Drug Treatment Update Scheduled...
PAO Group, Inc. (PAOG) FDA Application Process For Respiratory Cannabis Drug Treatment Update Scheduled This Friday
Sugarmade (SGMD) Issues Letter to Shareholders on Coming Expansion Steps
The new PetVivo medical device facility, primarily dedicated to the manufacture of its veterinary medical device for the treatment of osteoarthritis (OA), KUSH™ will serve as the primary location for PetVivo medical device operations, which provides manufacturing capabilities to produce up to 500,000 syringes of Kush that could generate over $100 million in revenue annually.
American Cannabis Company, Inc. (AMMJ) Announces Approval for Suitability by Colorado’s Marijuana Enforcement Division...
American Cannabis Company, Inc. (AMMJ) Announces Approval for Suitability by Colorado's Marijuana Enforcement Division (MED) and Provides Company Update
Tauriga Sciences Inc. (TAUG) Officially Approved to Operate as a U.S. Government Vendor